PointState Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-309,004
| Closed | -$23M | – | 68 |
|
2022
Q2 | $23M | Buy |
+309,004
| New | +$23M | 0.57% | 23 |
|
2022
Q1 | – | Sell |
-65,000
| Closed | -$7.28M | – | 125 |
|
2021
Q4 | $7.28M | Sell |
65,000
-130,028
| -67% | -$14.6M | 0.12% | 49 |
|
2021
Q3 | $24.5M | Buy |
+195,028
| New | +$24.5M | 0.41% | 37 |
|
2021
Q2 | – | Sell |
-50,000
| Closed | -$6.78M | – | 138 |
|
2021
Q1 | $6.78M | Buy |
+50,000
| New | +$6.78M | 0.13% | 73 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 144 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 106 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 134 |
|
2019
Q3 | – | Sell |
-22,800
| Closed | -$2M | – | 127 |
|
2019
Q2 | $2M | Buy |
+22,800
| New | +$2M | 0.04% | 77 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 135 |
|
2018
Q1 | – | Sell |
-12,200
| Closed | -$1.04M | – | 186 |
|
2017
Q4 | $1.04M | Buy |
+12,200
| New | +$1.04M | 0.01% | 117 |
|
2016
Q2 | – | Sell |
-19,200
| Closed | -$992K | – | 128 |
|
2016
Q1 | $992K | Buy |
+19,200
| New | +$992K | 0.03% | 79 |
|